Stature of young people with malignant bone tumors
Background Little is known about the aetiology of primary bone tumours. There have been conflicting reports relating to stature in young people with bone cancer. Patients We analysed height data at diagnosis for 364 patients with osteosarcoma and 356 patients with Ewing sarcoma registered on clinica...
Saved in:
Published in | Pediatric Blood & Cancer Vol. 42; no. 1; pp. 59 - 63 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.01.2004
Wiley |
Subjects | |
Online Access | Get full text |
ISSN | 1545-5009 1545-5017 1096-911X |
DOI | 10.1002/pbc.10437 |
Cover
Summary: | Background
Little is known about the aetiology of primary bone tumours. There have been conflicting reports relating to stature in young people with bone cancer.
Patients
We analysed height data at diagnosis for 364 patients with osteosarcoma and 356 patients with Ewing sarcoma registered on clinical trials run by the Medical Research Council (MRC) and the United Kingdom Children's Cancer Study Group (UKCCSG).
Main Outcome Measures
Height at diagnosis for each patient was standardised for age and sex compared to national reference data with a standard deviation score (SDS) calculated for each subject.
Results
Those with osteosarcoma were significantly taller than the general population (mean height SDS 0.2, P = 0.001). Patients with osteosarcoma of the femur were significantly taller than patients with other primary sites (mean height SDS 0.45 vs. −0.06, P = 0.0001). Overall those with Ewing sarcoma were not significantly taller than the general population (mean height SDS 0.09, P = 0.1), but children presenting under 15 years were taller (SDS 0.2, P = 0.004) whilst older patients were not (SDS −0.07, P = 0.4). In both osteosarcoma and Ewing sarcoma the mean age at diagnosis for females was significantly younger than for males.
Conclusions
This study suggests that tall stature and an earlier pubertal growth spurt may be important factors in the aetiology of both osteosarcoma and Ewing sarcoma. © 2003 Wiley‐Liss, Inc. |
---|---|
Bibliography: | ark:/67375/WNG-J9BQL9GP-0 ArticleID:PBC10437 North of England Children's Cancer Research Fund (to SC) istex:839F9F89C6976B49298D89A92652D4431A41E410 This manuscript was originally submitted to and accepted for publication in Medical & Pediatric Oncology by its Editor-in-Chief, Dr. G. D'Angio. On behalf of the UKCCSG/MRC Bone Tumour Working Group. Medical & Pediatric Oncology by its Editor‐in‐Chief, Dr. G. D'Angio. This manuscript was originally submitted to and accepted for publication in ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1545-5009 1545-5017 1096-911X |
DOI: | 10.1002/pbc.10437 |